Education
About Us
Working with TipRanks
Follow Us
Abivax SA Sponsored ADR (ABVX)
:ABVX
Total Valuation
Abivax SA Sponsored ADR has a market cap or net worth of $500.10M. The enterprise value is $386.64M.
Market Cap$500.10M
Enterprise Value$386.64M
Share Statistics
Abivax SA Sponsored ADR has 63,471,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,471,930
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Abivax SA Sponsored ADR’s return on equity (ROE) is -4.34 and return on invested capital (ROIC) is -110.77%.
Return on Equity (ROE)-4.34
Return on Assets (ROA)-0.86
Return on Invested Capital (ROIC)-110.77%
Return on Capital Employed (ROCE)-1.54
Revenue Per Employee156.41K
Profits Per Employee-2.55M
Employee Count69
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Abivax SA Sponsored ADR is -2.53. Abivax SA Sponsored ADR’s PEG ratio is -0.19.
PE Ratio-2.53
PS Ratio0.00
PB Ratio10.66
Price to Fair Value10.98
Price to FCF-2.78
Price to Operating Cash Flow-2.78
PEG Ratio-0.19
Income Statement
In the last 12 months, Abivax SA Sponsored ADR had revenue of 10.79M and earned -176.24M in profits. Earnings per share was -2.80.
Revenue10.79M
Gross Profit10.79M
Operating Income-172.98M
Pretax Income-176.24M
Net Income-176.24M
EBITDA-171.88M
Earnings Per Share (EPS)-2.80
Cash Flow
In the last 12 months, operating cash flow was -111.48M and capital expenditures -320.00K, giving a free cash flow of -112.01M billion.
Operating Cash Flow-111.48M
Free Cash Flow-112.01M
Free Cash Flow per Share-1.76
Dividends & Yields
Abivax SA Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.34
52-Week Price Change-39.10%
50-Day Moving Average6.87
200-Day Moving Average7.67
Relative Strength Index (RSI)67.50
Average Volume (3m)297.53K
Important Dates
Abivax SA Sponsored ADR upcoming earnings date is Aug 11, 2025, During Market Hours (Confirmed).
Last Earnings DateJun 2, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend Date―
Financial Position
Abivax SA Sponsored ADR as a current ratio of 1.84, with Debt / Equity ratio of 237.03%
Current Ratio1.84
Quick Ratio1.84
Debt to Market Cap0.21
Net Debt to EBITDA0.27
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Abivax SA Sponsored ADR has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Abivax SA Sponsored ADR EV to EBITDA ratio is -2.32, with an EV/FCF ratio of -2.58.
EV to Sales36.95
EV to EBITDA-2.32
EV to Free Cash Flow-2.58
EV to Operating Cash Flow-2.59
Balance Sheet
Abivax SA Sponsored ADR has $144.36M in cash and marketable securities with €109.22M in debt, giving a net cash position of -$35.14M billion.
Cash & Marketable Securities$144.36M
Total Debt€109.22M
Net Cash-$35.14M
Net Cash Per Share-$0.55
Tangible Book Value Per Share$0.25
Margins
Gross margin is 100.00%, with operating margin of -1602.89%, and net profit margin of -1633.08%.
Gross Margin100.00%
Operating Margin-1602.89%
Pretax Margin-1633.08%
Net Profit Margin-1633.08%
EBITDA Margin-1592.69%
EBIT Margin-1602.88%
Analyst Forecast
The average price target for Abivax SA Sponsored ADR is $34.14, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$34.14
Price Target Upside340.52% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast18.47%